Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria

Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies

(2019) Josef Coresh et al.   Lancet Diabetes & Endocrinology

Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials

(2019) Hiddo J L Heerspink et al.   Lancet Diabetes & Endocrinology

Single- and multiple-dose escalation study to assess pharmacokinetics, pharmacodynamics and safety of oral esaxerenone in healthy Japanese subjects

(2018) Manabu Kato et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system

(2017) Erik Nilsson et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Renin–angiotensin system blockade: Finerenone

(2017) Luis M. Ruilope et al.   Nephrologie & Therapeutique

Aldosterone Blockade in CKD: Emphasis on Pharmacology

(2015) Michael H. Schwenk et al.   ADVANCES IN CHRONIC KIDNEY DISEASE

Early renin-angiotensin system intervention is more beneficial than late intervention in delaying end-stage renal disease in patients with type 2 diabetes

(2015) B. Schievink et al.   DIABETES OBESITY & METABOLISM

CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats

(2015) Kiyoshi Arai et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy

(2015) George L. Bakris et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Evidence-based Clinical Practice Guideline for CKD 2013

(2014)   Clinical and Experimental Nephrology

Diabetic Kidney Disease: A Report From an ADA Consensus Conference

(2014) Katherine R. Tuttle et al.   DIABETES CARE

The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014)

(2014)   HYPERTENSION RESEARCH

Aldosterone Blockade in Chronic Kidney Disease

(2014) Jamie S. Hirsch et al.   SEMINARS IN NEPHROLOGY

Association Between Remission of Macroalbuminuria and Preservation of Renal Function in Patients With Type 2 Diabetes With Overt Proteinuria

(2013) H. Yokoyama et al.   DIABETES CARE

Mineralocorticoid receptor blockade in addition to angiotensin converting enzyme inhibitor or angiotensin II receptor blocker treatment: An emerging paradigm in diabetic nephropathy

(2013) Thomas A. Mavrakanas et al.   European Journal of Internal Medicine

Effects of verapamil added-on trandolapril therapy in hypertensive type 2 diabetes patients with microalbuminuria: the BENEDICT-B randomized trial

(2010) Piero Ruggenenti et al.   JOURNAL OF HYPERTENSION

Revised Equations for Estimated GFR From Serum Creatinine in Japan

(2009) Seiichi Matsuo et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

The Management of Hyperkalemia in Patients with Cardiovascular Disease

(2009) Apurv Khanna et al.   AMERICAN JOURNAL OF MEDICINE

Effects of Dietary Sodium and Hydrochlorothiazide on the Antiproteinuric Efficacy of Losartan

(2008) L. Vogt et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY